| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |